Crohn's Disease and Colitis Trial, Recruiting NCT05835973 Sponsor: Hospices Civils de Lyon Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT05835973
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are aged between 18 and 64 years old.
  • People who have been diagnosed with Inflammatory Bowel Disease (a long-term condition causing inflammation in the digestive tract) for at least 3 months.
  • People whose disease has been in remission (well-controlled, with low or no symptoms) for at least 3 months, confirmed by both symptom scores and blood or stool test results showing no active inflammation.
  • People who are willing and able to sign a consent form agreeing to take part in the study.
  • People who are covered by a social security or health insurance plan (confirm with trial site, as this requirement may be specific to France).

Who may not be able to join:

  • People who have had complications such as bowel blockages, fistulas (abnormal connections between organs), or abscesses (pockets of infection) in the abdomen within the past three months.
  • People who have had a large section of the small bowel removed (more than 40 cm).
  • People who have a stoma bag, such as an ileostomy or colostomy.
  • People who have been diagnosed with a sleep disorder.
  • People who are not legally able to give their own consent to participate.
  • People who are pregnant, recently given birth, or currently breastfeeding.
  • People who are currently detained or imprisoned by a court or government decision.
  • People who are currently receiving psychiatric care.
  • People who are living in a health or social care facility for reasons unrelated to research.
  • People who are adults under a formal legal protection arrangement, such as guardianship.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33 4 78 86 13 02

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
8 April 2025
Est. completion
8 April 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

rate of relapse

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov